These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Acquisition of aneuploidy provides increased fitness during the evolution of antifungal drug resistance. Selmecki AM; Dulmage K; Cowen LE; Anderson JB; Berman J PLoS Genet; 2009 Oct; 5(10):e1000705. PubMed ID: 19876375 [TBL] [Abstract][Full Text] [Related]
6. The synergistic antifungal effects of gypenosides combined with fluconazole against resistant Candida albicans via inhibiting the drug efflux and biofilm formation. Liu Y; Ren H; Wang D; Zhang M; Sun S; Zhao Y Biomed Pharmacother; 2020 Oct; 130():110580. PubMed ID: 32745913 [TBL] [Abstract][Full Text] [Related]
7. Fluconazole assists berberine to kill fluconazole-resistant Candida albicans. Li DD; Xu Y; Zhang DZ; Quan H; Mylonakis E; Hu DD; Li MB; Zhao LX; Zhu LH; Wang Y; Jiang YY Antimicrob Agents Chemother; 2013 Dec; 57(12):6016-27. PubMed ID: 24060867 [TBL] [Abstract][Full Text] [Related]
8. Antifungal Tolerance and Resistance Emerge at Distinct Drug Concentrations and Rely upon Different Aneuploid Chromosomes. Yang F; Scopel EFC; Li H; Sun LL; Kawar N; Cao YB; Jiang YY; Berman J mBio; 2023 Apr; 14(2):e0022723. PubMed ID: 36877011 [TBL] [Abstract][Full Text] [Related]
9. Deletion of Cryptococcus neoformans AIF ortholog promotes chromosome aneuploidy and fluconazole-resistance in a metacaspase-independent manner. Semighini CP; Averette AF; Perfect JR; Heitman J PLoS Pathog; 2011 Nov; 7(11):e1002364. PubMed ID: 22114551 [TBL] [Abstract][Full Text] [Related]
10. Aneuploidy Mediates Rapid Adaptation to a Subinhibitory Amount of Fluconazole in Candida albicans. Sun LL; Li H; Yan TH; Fang T; Wu H; Cao YB; Lu H; Jiang YY; Yang F Microbiol Spectr; 2023 Feb; 11(2):e0301622. PubMed ID: 36853047 [TBL] [Abstract][Full Text] [Related]
11. In vitro synergy of pseudolaric acid B and fluconazole against clinical isolates of Candida albicans. Guo N; Ling G; Liang X; Jin J; Fan J; Qiu J; Song Y; Huang N; Wu X; Wang X; Deng X; Deng X; Yu L Mycoses; 2011 Sep; 54(5):e400-6. PubMed ID: 21910756 [TBL] [Abstract][Full Text] [Related]
12. Azole drugs are imported by facilitated diffusion in Candida albicans and other pathogenic fungi. Mansfield BE; Oltean HN; Oliver BG; Hoot SJ; Leyde SE; Hedstrom L; White TC PLoS Pathog; 2010 Sep; 6(9):e1001126. PubMed ID: 20941354 [TBL] [Abstract][Full Text] [Related]
13. The calcineruin inhibitor cyclosporine a synergistically enhances the susceptibility of Candida albicans biofilms to fluconazole by multiple mechanisms. Jia W; Zhang H; Li C; Li G; Liu X; Wei J BMC Microbiol; 2016 Jun; 16(1):113. PubMed ID: 27316338 [TBL] [Abstract][Full Text] [Related]
14. Antifungal effects and potential mechanisms of lonidamine in combination with fluconazole against Chen X; Shi Y; Li Y; Su S; Wang P; Sun S Expert Rev Anti Infect Ther; 2021 Jan; 19(1):109-115. PubMed ID: 32924656 [TBL] [Abstract][Full Text] [Related]
15. Short-term exposure to fluconazole induces chromosome loss in Candida albicans: an approach to produce haploid cells. Chang FM; Ou TY; Cheng WN; Chou ML; Lee KC; Chin YP; Lin CP; Chang KD; Lin CT; Su CH Fungal Genet Biol; 2014 Sep; 70():68-76. PubMed ID: 25038494 [TBL] [Abstract][Full Text] [Related]
16. ABC transporter Cdr1p contributes more than Cdr2p does to fluconazole efflux in fluconazole-resistant Candida albicans clinical isolates. Holmes AR; Lin YH; Niimi K; Lamping E; Keniya M; Niimi M; Tanabe K; Monk BC; Cannon RD Antimicrob Agents Chemother; 2008 Nov; 52(11):3851-62. PubMed ID: 18710914 [TBL] [Abstract][Full Text] [Related]
17. Antifungal activity of Rubus chingii extract combined with fluconazole against fluconazole-resistant Candida albicans. Han B; Chen J; Yu YQ; Cao YB; Jiang YY Microbiol Immunol; 2016 Feb; 60(2):82-92. PubMed ID: 26891940 [TBL] [Abstract][Full Text] [Related]
18. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment. Jensen RH Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142 [TBL] [Abstract][Full Text] [Related]
19. Candida and candidaemia. Susceptibility and epidemiology. Arendrup MC Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246 [TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo antifungal activities of FX0685, a novel triazole antifungal agent with potent activity against fluconazole-resistant Candida albicans. Takahata S; Okutomi T; Ohtsuka K; Hoshiko S; Uchida K; Yamaguchi H Med Mycol; 2005 May; 43(3):227-33. PubMed ID: 16010849 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]